Regina Brown's most recent trade in Blackstone Inc was a trade of 1,961 Common Stock done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 1,961 | 21,462 (0%) | 0% | 0 | Common Stock | |
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2025 | 1,150 | 19,501 (0%) | 0% | 0 | Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 12,600 | 12,600 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 9,508 | 9,508 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2025 | 4,924 | 4,924 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | 30 Sep 2024 | 6,269 | 6,269 | - | - | Options to Purchase Common Stock | ||
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 1,402 | 18,351 (0%) | 0% | 0 | Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | 30 Jun 2024 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Regina Brown | Director | 30 Jun 2024 | 4,904 | 4,904 | - | - | Options to Purchase Common Stock | ||
| Blackstone | Brown Reginald J. | Director | Purchase of securities on an exchange or from another person at price $ 125.62 per share. | 21 Feb 2024 | 2,400 | 16,949 (0%) | 0% | 125.6 | 301,500 | Common Stock |
| Blackstone | Reginald J. Brown | Director | Purchase of securities on an exchange or from another person at price $ 111.24 per share. | 21 Sep 2023 | 1,842 | 14,549 (0%) | 0% | 111.2 | 204,904 | Common Stock |
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2023 | 1,842 | 12,707 (0%) | 0% | 0 | Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | 30 Jun 2023 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Regina Brown | Director | 21 Nov 2022 | 2,600 | 6,300 | - | 0.6 | 1,508 | Common Stock | |
| Lixte biotech Holdings Inc | Regina Brown | Director | 21 Nov 2022 | 2,400 | 3,700 | - | 0.6 | 1,368 | Common Stock | |
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 2,230 | 10,865 (0%) | 0% | 0 | Common Stock | |
| Blackstone | Reginald J. Brown | Director | Purchase of securities on an exchange or from another person at price $ 99.35 per share. | 28 Jul 2022 | 3,100 | 8,635 (0%) | 0% | 99.4 | 307,986 | Common Stock |
| Lixte biotech Holdings Inc | Regina Brown | Director | 30 Jun 2022 | 100,000 | 100,000 | - | - | Options to Purchase Common Stock | ||
| Blackstone | Reginald J. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 1,582 | 5,535 (0%) | 0% | 0 | Common Stock |